FREE delivery to all EXCLUSIVE BOOKS stores nationwide. FREE delivery to your door on all orders over R450. Excludes all international deliveries.

DNA Topoisomerases in Cancer Therapy

Toshiwo Andoh
    Product form
      FORMAT: Hardback

      R 3,490.34 Price and availability exclusive to website

      YOU COULD EARN 3,490.34 FUTURE RETAIL DISCOUNTS.
      ESTIMATED DELIVERY: Approx. 10 - 15 Business Days
      BUY NOW PAY LATER
      From R 581.72 per month!
      3x monthly payments of R 1,163.44 with
      4x fortnightly payments of R 872.58 with
      In the mid 80's type I and II enzymes were found to be the intracellular targets of a number of efficacious anticancer drugs such as doxorubicin, mitoxantrone, etoposide and camptothecin as a result of a continued efforts of many investigators, especially Leroy Liu and his collaborators at Johns Hopkins University. Readers will find a series of chapters written by researchers actively engaged in the expanding field of topoisomerase and their inhibitors. The series of chapters cover review articles on pharmacology and the molecular mechanism of topoisomerase I- and II-targeting anticancer drugs in mammals and in the yeast Saccharomyces cerevisiae, which has proved to be a superb model organism for studies of anticancer drugs. This volume compiles up-to-date information on the topoisomerase-targeting compounds in clinical and preclinical development as a useful and important reference book for students and researchers in the field of pharmacology, toxicology, oncology and molecular biology.
      Format: CONTRIBUTORS: Toshiwo Andoh EAN: 9780306477447 COUNTRY: United States PAGES: WEIGHT: 541 g HEIGHT: 235 cm
      PUBLISHED BY: Springer Science+Business Media DATE PUBLISHED: 2003-06-30 CITY: GENRE: MEDICAL / Biochemistry, MEDICAL / Oncology / General, SCIENCE / Life Sciences / Biochemistry WIDTH: 155 cm SPINE:

      Book Themes:

      Oncology, Medicinal chemistry, Biochemistry

      Customer Reviews

      Be the first to write a review
      0%
      (0)
      0%
      (0)
      0%
      (0)
      0%
      (0)
      0%
      (0)
      In the mid 80's type I and II enzymes were found to be the intracellular targets of a number of efficacious anticancer drugs such as doxorubicin, mitoxantrone, etoposide and camptothecin as a result of a continued efforts of many investigators, especially Leroy Liu and his collaborators at Johns Hopkins University. Readers will find a series of chapters written by researchers actively engaged in the expanding field of topoisomerase and their inhibitors. The series of chapters cover review articles on pharmacology and the molecular mechanism of topoisomerase I- and II-targeting anticancer drugs in mammals and in the yeast Saccharomyces cerevisiae, which has proved to be a superb model organism for studies of anticancer drugs. This volume compiles up-to-date information on the topoisomerase-targeting compounds in clinical and preclinical development as a useful and important reference book for students and researchers in the field of pharmacology, toxicology, oncology and molecular biology.
      Format: CONTRIBUTORS: Toshiwo Andoh EAN: 9780306477447 COUNTRY: United States PAGES: WEIGHT: 541 g HEIGHT: 235 cm
      PUBLISHED BY: Springer Science+Business Media DATE PUBLISHED: 2003-06-30 CITY: GENRE: MEDICAL / Biochemistry, MEDICAL / Oncology / General, SCIENCE / Life Sciences / Biochemistry WIDTH: 155 cm SPINE:

      Book Themes:

      Oncology, Medicinal chemistry, Biochemistry

      Customer Reviews

      Be the first to write a review
      0%
      (0)
      0%
      (0)
      0%
      (0)
      0%
      (0)
      0%
      (0)

      Recently viewed products

      Login

      Forgot your password?

      Don't have an account yet?
      Create account